Cargando…

α-Gal A missense variants associated with Fabry disease can lead to ER stress and induction of the unfolded protein response

Anderson-Fabry Disease (FD) is an X-linked lysosomal disorder caused by mutations in GLA, the gene encoding the lysosomal hydrolase α-galactosidase A (α-Gal A), leading to accumulation of glycosphingolipids in the lysosomes. FD is a multisystemic disorder leading to progressive cardiovascular, cereb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Consolato, Francesco, De Fusco, Maurizio, Schaeffer, Céline, Pieruzzi, Federico, Scolari, Francesco, Gallieni, Maurizio, Lanzani, Chiara, Feriozzi, Sandro, Rampoldi, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636577/ https://www.ncbi.nlm.nih.gov/pubmed/36345359 http://dx.doi.org/10.1016/j.ymgmr.2022.100926

Ejemplares similares

FAbry STabilization indEX (FASTEX): an innovative tool for the assessment of clinical stabilization in Fabry disease
por: Mignani, Renzo, et al.
Publicado: (2016)

Leader peptide or pro-segment mutants of renin are misrouted to mitochondria in autosomal dominant tubulointerstitial kidney disease
por: Schaeffer, Céline, et al.
Publicado: (2023)

New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases
por: Mignani, Renzo, et al.
Publicado: (2018)

New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases
por: Mignani, Renzo, et al.
Publicado: (2019)

Fabry nephropathy: a review – how can we optimize the management of Fabry nephropathy?
por: Waldek, Stephen, et al.
Publicado: (2014)

The GALA project: practical recommendations for the use of migalastat in clinical practice on the basis of a structured survey among Italian experts
por: Chimenti, Cristina, et al.
Publicado: (2020)

Mutant uromodulin expression leads to altered homeostasis of the endoplasmic reticulum and activates the unfolded protein response
por: Schaeffer, Céline, et al.
Publicado: (2017)

Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD
por: Econimo, Laura, et al.
Publicado: (2022)

Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?
por: Duro, Giovanni, et al.
Publicado: (2018)

Prompt Agalsidase Alfa Therapy Initiation is Associated with Improved Renal and Cardiovascular Outcomes in a Fabry Outcome Survey Analysis
por: Hughes, Derralynn, et al.
Publicado: (2021)

Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study
por: Mignani, Renzo, et al.
Publicado: (2021)

Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?
por: Hughes, Derralynn A., et al.
Publicado: (2022)

Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease
por: Cybulla, Markus, et al.
Publicado: (2022)

Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data
por: Riccio, Eleonora, et al.
Publicado: (2020)

Autosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein
por: Schaeffer, Céline, et al.
Publicado: (2019)

ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?
por: Féral, Kelly, et al.
Publicado: (2021)

Comparison of efficacy between subcutaneous and intravenous application of moss‐aGal in the mouse model of Fabry disease
por: Dabrowska‐Schlepp, Paulina, et al.
Publicado: (2023)

Relapsing minimal change disease superimposed on late-onset p.N215S Fabry nephropathy
por: Salerno, Fabio R, et al.
Publicado: (2021)

Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy
por: Salerno, Fabio R, et al.
Publicado: (2022)

Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease
por: Rossi, Federica, et al.
Publicado: (2021)

Virus-induced ER stress and the unfolded protein response
por: Zhang, Lingrui, et al.
Publicado: (2012)

ER Stress and Unfolded Protein Response in Cancer Cachexia
por: Roy, Anirban, et al.
Publicado: (2019)

Tolerization of Anti–Galα1-3Gal Natural Antibody–forming B Cells by Induction of Mixed Chimerism
por: Yang, Yong-Guang, et al.
Publicado: (1998)

Identification of a Missense Mutation in the α-galactosidase A Gene in a Chinese Family with Fabry Disease
por: Wu, Yuan, et al.
Publicado: (2018)

ER Stress, the Unfolded Protein Response and Osteoclastogenesis: A Review
por: Huang, Wangli, et al.
Publicado: (2023)

Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry disease
por: Delprete, C., et al.
Publicado: (2023)

Roles for H2A.Z and Its Acetylation in GAL1 Transcription and Gene Induction, but Not GAL1-Transcriptional Memory
por: Halley, Jeffrey E., et al.
Publicado: (2010)

High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: Commentary
por: Cosmai, Laura, et al.
Publicado: (2023)

ZFN-mediated in vivo gene editing in hepatocytes leads to supraphysiologic α-Gal A activity and effective substrate reduction in Fabry mice
por: Pagant, Silvere, et al.
Publicado: (2021)

Migalastat Treatment in a Kidney-Transplanted Patient with Fabry Disease and N215S Mutation: The First Case Report
por: Di Stefano, Valeria, et al.
Publicado: (2021)

The unfolded protein response links ER stress to cancer-associated thrombosis
por: Muse, Oluwatoyosi, et al.
Publicado: (2023)

Keratin 12 missense mutation induces the unfolded protein response and apoptosis in Meesmann epithelial corneal dystrophy
por: Allen, Edwin H.A., et al.
Publicado: (2016)

The Unfolded Protein Response at the Tumor-Immune Interface
por: Zanetti, Maurizio, et al.
Publicado: (2022)

Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study
por: Germain, Dominique P., et al.
Publicado: (2018)

Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience
por: Riccio, Eleonora, et al.
Publicado: (2020)

Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial
por: Scolari, Francesco, et al.
Publicado: (2019)

Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease
por: Lindholm, Dan, et al.
Publicado: (2017)

Effects of Jasmonic Acid in ER Stress and Unfolded Protein Response in Tomato Plants
por: Czékus, Zalán, et al.
Publicado: (2020)

Confounding Roles of ER Stress and the Unfolded Protein Response in Skeletal Muscle Atrophy
por: Gallot, Yann S., et al.
Publicado: (2021)

3-Ketodihydrosphingosine reductase maintains ER homeostasis and unfolded protein response in leukemia
por: Liu, Qiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v8q2oe8l7ktilueffg79bjptnv